4 research outputs found

    Optimized Microstrip Antennas with Metamaterial Superstrates Using Particle Swarm Optimization

    Full text link
    Two new designs of compact microstrip antennas, where metamaterials are placed on structure as superstrate, are proposed. The newly designed metamaterial unit cell and antenna feed position optimized by particle swarm optimization. It was found that the characteristics of novel microstrip antennas with designed metamaterials placed on the superstrate are comparable to the conventional patch antennas, while their gain, directivity and radiating efficiency are noticeably improved. Gain of microstrip antenna is increased 3dB to 4dB and level of back lobe is decresed

    Antibody-Mediated Osseous Regeneration for Bone Tissue Engineering in Canine Segmental Defects

    No full text
    Among many applications of therapeutic monoclonal antibodies (mAbs), a unique approach for regenerative medicine has entailed antibody-mediated osseous regeneration (AMOR). In an effort to identify a clinically relevant model of craniofacial defect, the present study investigated the efficacy of mAb specific for bone morphogenetic protein- (BMP-) 2 to repair canine segmental mandibular continuity defect model. Accordingly, a 15 mm unilateral segmental defect was created in mandible and fixated with a titanium plate. Anorganic bovine bone mineral with 10% collagen (ABBM-C) was functionalized with 25 μg/mL of either chimeric anti-BMP-2 mAb or isotype-matched mAb (negative control). Recombinant human (rh) BMP-2 served as positive control. Morphometric analyses were performed on computed tomography (CT) and histologic images. Bone densities within healed defect sites at 12 weeks after surgery were 1360.81 ± 10.52 Hounsfield Unit (HU), 1044.27 ± 141.16 HU, and 839.45 ± 179.41 HU, in sites with implanted anti-BMP-2 mAb, rhBMP-2, and isotype mAb groups, respectively. Osteoid bone formation in anti-BMP-2 mAb (42.99% ± 8.67) and rhBMP-2 (48.97% ± 2.96) groups was not significantly different but was higher (p<0.05) than in sites with isotype control mAb (26.8% ± 5.35). In view of the long-term objective of translational application of AMOR in humans, the results of the present study demonstrated the feasibility of AMOR in a large clinically relevant animal model
    corecore